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Abstract
Background: This experimental study was designed to investigate the differences in pattern of
local growth and diffusion of colorectal cancer cells injected into either mesenteric (M) or
antimesenteric (AM) sides of the colon.
Methods: A total of 1 × 106 colonic adenocarcinoma cells (line DHD/K12-TRb) were injected into
the cecal wall of BDIX syngeneic male rats at an M or AM site of the colon. At six weeks after
injection, all animals were sacrificed and the presence or absence of tumor in the cecum as well as
regional metastasis and peritoneal carcinomatosis were determined.
Results: Six weeks after injection, macroscopic tumor growth was observed in 27/37 (72%)
animals in group M and 21/32 (65%) in group AM (P = 0.98). In group AM, diffuse peritoneal
carcinomatosis was present in 19/21 rats (90.4%) versus 3/27 rats (11%) in group M; this difference
was statistically significant (P = 0.025). Regional mesenteric lymph nodes were the only location in
which tumor was detected in 23/27 rats (85%) in group M versus 2/21 (9.5%) in group AM; this
difference too was statistically significant (P = 0.031)
Conclusion: The patterns of diffusion of tumors implanted in mesenteric and antimesenteric sites
of the colon appear to be different, although the reason for this is not clear.
Background
Colorectal cancer is the second leading cause of death
from tumors in the world with a worldwide incidence of
more than 1 million cases [1]. As for most malignant
tumors, the degree of infiltration of the colonic wall (T
stage) and presence of lymph node/ distant (N and M
stage) metastases have been demonstrated to be strongly
related to prognosis [2]. Identifying the pattern of cancer
spread (local and distant) may be important in choosing
the appropriate surgical and medical, strategies in relation
to various factors, such as tumor location and site of
growth.
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Several experimental models have been developed to
examine colorectal cancer kinetics, but most are based on
heterotopic cell implantation (i.e. peritoneal, subcutane-
ous, etc.) [3,4] both in nude and syngeneic rats [5,6].
Other investigators have developed orthotopic models in
which tumor implantation is performed directly into the
wall of the colon of healthy rats, in order to study patterns
of local growth and metastatic spread [7,8].
The present experimental study was designed to investi-
gate the differences in pattern of local growth and diffu-
sion of colorectal cancer cells injected into either
mesenteric (M) or antimesenteric (AM) sides of the colon.
Such differences may be of clinical importance, since
metastases and diffusion could be influenced by tumor
location.
Materials and methods
Animals
BDIX syngeneic male rats (Charles Rivers Italia – Lecco,
Italy) with a mean weight of 290 ± 15 g were used for all
experiments. They were kept in protective cages with con-
trolled air in/outflow and allowed free access to food and
water. They were divided into two groups, mesenteric (M)
and antimesenteric (AM), of 40 rats each.
Intraparietal injection of colonic cancer cells (mesenteric injection) Figure 1
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Tumor cell line
The colonic adenocarcinoma cell line DHD/K12-TRb
(European Collection of Cell Culture, Salisbury, Wiltshire
– UK) was used in all experiments. These cells were cloned
[3] from a 1,2-dimethylhydrazine-induced colonic aden-
ocarcinoma and maintained in monolayers using DMEM
medium enriched with Ham's F10 (1:1, v/v; GIBCO, Life
Technologies, Paisley, UK) supplemented with 10% fetal
bovine serum (GIBCO) and 0.005% gentamycin
(GIBCO). The cells were divided every 72 hours after dis-
persion in 0.125% EDTA-trypsin.
Prior to injection, cells viability was confirmed by trypan-
blue test, and was found to be greater than 95% in all
cases.
Tumor implantation model and experimental procedure
Each animal was anaesthetized by intraperitoneal injec-
tion of 75 mg/kg of ketamine (Sigma-Aldrigh, Italy). A 2
cm midline laparotomy was performed and the cecum
was exposed. Intraparietal injection (Fig. 1) of 1 × 106 cells
in 0.25 ml of buffer solution was performed in a
mesenteric (Group M) or antimesenteric (Group AM) side
of the cecum (Figure 1).
Extreme care was taken to avoid accidental spillage of cells
into the abdominal cavity or tumor injection directly into
the bowel lumen: the creation of a macroscopically visible
blister in the bowel wall was required for confirmation of
intra-parietal injection. The laparotomy was closed with
reabsorbable 3/0 suture.
Mesenteric growth of implanted colonic cancer Figure 2
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At six week after injection, all animals were sacrificed with
a lethal dose of sodium thiopental (Sigma-Aldrigh, Italy)
A wide xiphopubic incision was performed and the pres-
ence or absence of tumor in the cecum as well as regional
metastasis (Figure 2) and peritoneal carcinomatosis (Fig-
ure 3) was recorded. Histopathological examination of
the primary tumor and metastases was always performed
to confirm the features of the specimen.
Statistical analysis
Student's t-test was used to compare numbers of tumor
lesions and the characteristics of diffusion, with P-values
less than 0.05 considered significant.
Results
Three animals in group M and 8 in group AM died due to
cardiorespiratory arrest during anesthesia or immediately
after the procedure. Six weeks after tumor cell injection,
macroscopic tumor growth was observed in 27/37 (72%)
animals in group M and 21/32 (65%) in group AM; this
difference was not significant (P = 0.98).
In group AM, diffuse peritoneal carcinomatosis (Figure 3)
was present in 19/21 rats (90.4%) versus 3/27 cases
(11%) in group M (Figure 4); this difference was statisti-
cally significant (P = 0.025).
Regional mesenteric lymph nodes (Figure 2) (located near
tumor growth) were the only manifestation of tumor dif-
fusion in 23/27 rats (85%) in group M versus 2/21 (9.5%)
Peritoneal carcinomatosis after antimesenteric implantation of cancer cells Figure 3
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in group AM (Figure 5); this difference was significant (P
= 0.031). No liver or lung metastases were observed in
either group. Histological confirmation of the presence of
cancer cells was obtained in all cases.
Discussion
Study of the kinetics of local growth and metastatic diffu-
sion of cancers is extremely important for increasing
knowledge of the natural history of the tumors and for
determination of appropriate surgical strategies and/or
medical therapies.
Although experimental models are the best means for
study of tumor kinetics, exposure of animals to carcino-
genic agents results in excessive variability such as differ-
ences in differentiation, location and diffusion. On the
contrary, implantation of cancer cells or solid tumor,
directly into the site to be studied, it can reproduce a
standard condition more suitable for this kind of studies
[3-7].
Several experimental models of free cancer cell implanta-
tion into the wall of the colon have been described [3,4].
The animal model used in our experiments is well-estab-
lished, since it has been fully demonstrated that DHD/
K12/TRb colonic cancer cells are able to grow when
injected subcutaneously, intraperitoneally and in the wall
of the colon [3-5]. Nevertheless, some of these studies
used nude animals, in which unusual immunological sta-
tus may result in great difficulty in interpretation of
results.
In our study, the incidence of tumor growth after implan-
tation was almost 65%; similar results have been reported
by other studies [4,7]. Incorrect parietal injection, low via-
bility of tumor cells, intraluminar injection, or host
Incidence of peritoneal carcinomatosis in groups M and AM (P = 0.025) Figure 4
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immune response to cancer cells may be explanations of
the 65% tumor growth incidence.
Garcia Almo et al, [7], injecting DHD/K12/TRb cells into
the cecal wall of syngeneic rats, demonstrated progressive
tumor growth from stage T1 to stage T4, as well as lymph
node involvement and distant metastases, reproducing
the same progressive development as occurs in human
colon cancer. Nevertheless, with this kind of injection
model, it seems to be extremely difficult to perform pre-
cise implantation into the mucosa and to enable progres-
sive tumor growth corresponding to that observed
clinically.
In order to avoid accidental spillage of tumor cells and
induce true local growth, Balague et al, [8] developed a
model in which solid tumors, derived from DHD/K12/
TRb colonic cancer cells, were implanted into the wall of
the colon. Nevertheless, variability in the number of
viable cells contained in a single piece of implanted tumor
may result in misinterpretation of results.
None of the above studies considered difference in tumor
implantation side, mesenteric or antimesenteric, as affect-
ing local growth and distant metastases.
This difference might be of clinical significance, since cer-
tain locations can result in more aggressive tumor behav-
ior due to particular anatomical patterns of blood or
lymphatic vessels. In our study, when injection of tumor
cells was performed in the mesenteric site of the colon,
cancer grew locally and spread to the regional mesenteric
lymph nodes. On the other hand, with antimesenteric
implantation, there was lymph node metastasis but a high
incidence of peritoneal carcinomatosis.
Proximity to larger blood and lymphatic vessels of the
mesenteric site of the colon could explain the tendency of
Incidence of mesenteric growth in groups M and AM (P = 0.031) Figure 5
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implanted cells to spread to regional nodes. When cancer
cells are injected into the antimesenteric wall, peritoneal
diffusion appears to be promoted, probably due to direct
contact of the tumor with loops of bowel and the
peritoneum.
Another explanation may be related to differences in
microvascular pattern of the wall of the colon.
Preliminary results of an experimental vascular casting
study that we are performing in collaboration with the
Department of Human Anatomy, seem to support the the-
ory that the antimesenteric side of the colon differs signif-
icantly from the mesenteric side in microvascular arterial
density and distribution (unpublished data).
Since M and N stage are the most important prognostic
factors in human colorectal cancer [2], differences in local
and metastatic diffusion of cancers located on the
mesenteric or antimesenteric sites of the colon may be of
clinical importance [9].
Conclusion
The experimental model used in this study is able to
induce local growth as well as peritoneal carcinomatosis
in rats by parietal injection of malignant cells. The pattern
of diffusion of tumors implanted at mesenteric and
antimesenteric sites of the colon appear to differ,
although the reason for this difference is unclear. Proxim-
ity of larger blood and lymphatic vessels or differences in
vascular pattern in the wall of the colon between
mesenteric and antimesenteric sites might account for
these findings. Further clinical studies are needed to con-
firm the prognostic significance of the location of colorec-
tal cancer in humans.
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